Abstract
Introduction

Nuclear factor B (NF-B) is an important transcription factor typically activated by pro-inflammatory cytokines and other specific stimuli and is involved in the regulation of a variety of biological responses. It was initially identified as a protein that binds to a specific DNA sequence within the intronic enhancer of the immunoglobulin light chain in mature B and plasma cells [1]. It has subsequently been shown to be a ubiquitously expressed transcription factor that plays a critical role in the regulation of inflammatory, apoptotic and immune processes. It achieves this by regulating the expression of proteins such as cytokines, chemokines, adhesion molecules and the cellular death cascade [2-4]. The critical role played by NF-B is demonstrated by the fact that it has been implicated in the pathogenesis of many diseases with an immune or inflammatory component/mechanism, including H. pylori infection, ␣1 antitrypsin deficiency, acute respiratory distress syndrome, glomerulonephritis, septic shock and chronic diseases such as rheumatoid arthritis, inflammatory bowel disease, asthma, atherosclerosis and tumourigenesis
.
NF-B is constructed of homo-or heterodimers of a family of related proteins that share a common Rel homology domain. The family is made up of five proteins: p65, c-Rel, Rel B, p50/p105
and p52/p100. Both p105 and p100 are synthesized as precursor proteins that are processed to the smaller active forms of p50 and p52. The p65/p50 heterodimer is the most abundant form of the NF-B protein followed by the p50/p50 and p65/p65 homodimer complexes [2, [11] [12] [13] . [2] .
Activation of NF-B
Activation of NF-B is a complex process that is governed mainly by members of IB kinase (IKK) complex that are upstream of another set of regulator proteins called Inhibitor of B (IBs). IB proteins belong to a structurally and functionally distinct family whose members include IB-␣, IB-␤, IB-, IB-, Bcl-3, p100 and p105, all important regulators of NF-B [14]. In an unstimulated cell NF-B is sequestered in a complex with IB-␣, IB-␤ and IB-. Activation and nuclear translocation of NF-B in general requires the degradation of bound IBs, leading to the unmasking of the nuclear localization domain of NF-B. Degradation of IB-␣ necessitates its phosphorylation by IKK-␤ with subsequent processing by the ubiquitin-proteasomal system. This releases NF-B allowing it to translocate to the nucleus where it regulates gene expression
Various different stimuli, including oxidative stress, inflammatory cytokines, radiation, viruses and bacteria activate NF-B [15] . It [15, 16] [22] [23] [24] .
has been shown that signal pathways from these various stimuli converge mainly upon the IKK complex. This complex consists of three proteins, two of which, IKK-␣ and IKK-␤, are catalytic in activity while the third, IKK-␥/NF-B essential modulator (NEMO) has a regulatory role serving as an adapter protein, connecting both the catalytic subunits with the upstream activators. In the well-characterized canonical pathway, the IKK-␤ and IKK-␥/NEMO containing complex phosphorylates two critical serine residues in IB-␣ (Ser 32 and Ser 36) allowing targeting of the IB-␣ for ubiquitination and degradation
In [28] .
More recently, p100, the precursor of the p52 subunit, was reported to be a bonafide fourth member of the IB regulator family [29] . The authors identified that limited amounts of cytoplasmic p50/p65 was bound directly to p100 and that stimulation of the cells with LT␤R led to an increase in NF-B activity in a p100 dependent but IB independent manner. Interestingly it has also been reported that p100 itself is an NF-B target gene [29] . There are several reviews that provide extensive information about the function and mechanism of action of these classical regulators of NF-B [4, 12] . [31] . Interestingly IKK-␣ was also shown to cause phosphorylation of Histone H3 and increased transcription factor activity [31, 32] . Another member of the IKK complex, IKK-␥/NEMO has also been shown to shuttle between cytoplasm and nucleus [33] . Surprisingly NEMO does not possess the classical nuclear localization signal (NLS) [34] [35] [36] . (Table 1 and Fig. 1 ). These known nuclear regulators and their mechanism of action are elaborated upon in the following sections.
Identification of these nuclear localized, specific inhibitors of NF-B is intriguing and may enable a greater understanding of how NF-B activity is modulated in the nucleus. It has also been established that post-translational modification of NF-B within the nucleus by processes such as phosphorylation, acetylation and deacetylation are important for the regulation of its activity
B cell lymphoma 3 (Bcl-3)
Bcl-3 is a nuclear protein that preferentially promotes NF-Bdependent gene transcription [37] . Experiments with transgenic mice constitutively expressing Bcl-3 indicated that Bcl-3 associated with endogenous p50 and p52 [38] . Bcl-3 can cause derepression of transcription by removing p50 and p52 dimers, which are transcriptionally inactive, from the NF-B sites, thus leading to the binding of an active complex consisting of p65, Rel-B or c-Rel [39] .
While the ankyrin repeat domain of the Bcl-3 protein is essential for its activity as an IB, its N-and C-terminal regions are not homologous to those of other IB proteins, being very proline rich, which suggests a potential role as a transcriptional transactivator. Zhang et al. demonstrated that Bcl-3 co-localizes with the NF-B subunit p50 in a variety of punctate or speckled patterns strongly implying a interaction between these two proteins. This pattern of distribution, along with the proline rich sequence, corroborates the possible trans-activator nature of the protein as does the formation of a ternary complex with DNA and p50
homodimers [40] . [42] .
Bcl-3 is a crucial factor in the signal transduction pathways activated by a variety of pro-inflammatory ligands. For example, in cells stimulated with LPS, Bcl-3 facilitates production of TNF-␣ but not of IL-6 [41]. On the other hand, Bcl-3 inhibits IL-10 expression in macrophages in response to infection thus promoting activation of the innate immune system
Bcl-3 knockout mice exhibit severe defects in humoural immune responses and protection from in vivo challenges [43] . [46] . The contribution of Bcl-3 to tumour growth was further elaborated when it was reported that the cyclin D1 elevation seen in CYLD de-ubiquitinase gene knockout mice was mediated by increased activity of Bcl-3-associated p50 and p52 dimers [47] . [49, 50] . In this regard, Bcl-3 may be considered as a potential target for therapies centred on the NF-B pathway.
Bcl-3 plays a critical role in sustaining immune responses and is crucial for optimal T-cell function. Over-expression of Bcl-3 results
CYLD is an important negative regulator of Bcl-3 (and another important mediator of NF-B signals, TRAF2) causing Bcl-3 to be de-ubiquitinated, and therefore preventing its translocation to the nucleus. In addition, Bcl-3 expressing breast cancer cells have reduced duration of the G1 phase and increased phosphorylation of retinoblastoma protein thus promoting faster cell division rate [48]. Current evidence therefore suggests that Bcl-3 may play an important role in tumourigenesis via its regulation of NF-B. Recent evidence also points towards a contribution of NF-Bmediated inflammation in tumour progression
IB-
IB-is another recently described regulator of NF-B, which
shares a high degree of homology with Bcl-3 [35, 51] . The [59] . It has been reported that NF-B is constitutively active in a ZAS3-deficient cell line [34] and that ZAS3 deficiency leads to proliferation of cells leading to tumour formation in mice [60] . [63] .
Regulation of NF-B by ubiquitination has long been suggested to be an important factor in terminating its action. Indeed, in 2003 it was demonstrated that p65 protein stability is regulated by ubiquitin-mediated proteolysis and it was proposed that the cytokine signal inhibitor SOCS-1 was a putative p65 ubiquitin ligase [61]. However, more recently this process of NF-B regulation by ubiquitination was attributed to the PDLIM2 protein [62]. PDLIM2 is a member of the PDZ and LIM domain containing protein family and some members of this family are implicated in diverse biological roles including cytoskeletal organization, neuronal signalling, cell lineage specification, organ development and oncogenesis
However, unlike other members of this class, PDLIM2 itself was shown to inhibit NF-B activity by facilitating the polyubiquitination of the p65 subunit of NF-B in the nucleus [62]. For this activity, PDLIM2 functioned as an ubiquitin E3 ligase by means of its LIM domain, triggering the transfer of the soluble p65 fraction to the insoluble fraction within the promyelocytic leukaemia protein bodies in the nucleus and subsequently assisting the proteosomal degradation of p65 protein. Interestingly, PDLIM2 did not affect the cytoplasmic pool of p65, thus allowing for a critical pool of cytoplasmic p65 to remain enabling the cell to respond rapidly to subsequent stimulation.
Post-translational modification of NF-B complex in the nucleus
Proteins within the NF-B complex are subject to signal-induced post-translational modifications that influence their physiological functions. In addition to ubiquitination as discussed above, these include phosphorylation, hydroxylation and acetylation [64] [65] [66] . These modifications take place in the cytoplasm and/or the nucleus and within the nucleus their effects can range from transcriptional activation to repression. [65, 67] [68, 69] . One additional consequence of p65 phosphorylation is the increased recruitment of CBP/p300 leading to the export of repressor proteins such as HDACs [2, 70] . [71, 72] [73] .
Phosphorylation
Phosphorylation of proteins, a reversible process catalysed by kinases and phosphatases, enables various proteins to be regulated in a subtle manner. Of the Rel family members, phosphorylation of p65 has been most extensively analyzed. p65 is phosphorylated at nine different sites, including six serine and three threonine residues, with some occurring in the cytoplasm
. Of these, phosphorylation of the two residues Ser-468 and Ser-276 are known to affect nuclear function of NF-B. Phosphorylation of Ser-468 is mediated by glycogen synthase kinase -3 beta (GSK-3␤) and results in the inhibition of the basal activity of NF-B [65]. Ser-276, a target of mitogen-and stressactivated protein kinase 1 (MSK-1), is phosphorylated exclusively within the nucleus
Other members of Rel family including Both RelB and C-Rel also undergo phosphorylation but while phosphorylation promotes RelB degradation, it enhances C-Rel transactivation
. Of the described nuclear inhibitors of NF-B, Bcl-3 is known to undergo GSK-3␤ mediated phosphorylation causing it to be degraded via the proteasomal pathway
Acetylation and deacetylation
Transcription factors regulate gene expression by binding to a specific promoter sequence of the target gene [74] [77, 78] . In general, increased levels of histone acetylation are associated with increased transcription factor activity, whereas decreased levels of acetylation are associated with repression of gene expression [79] .
A [80] . These findings reveal how potentially different posttranslational modifications can synergistically or antagonistically fine-tune the outcome to NF-B activation.
potential role for acetylation in the regulation of NF-B mediated transactivation was reported by Chen and Greene who showed that TSA enhances B-luciferase reporter gene expression in cells stimulated by TNF-␣. p65 is acetylated by p300/CBP and deacetylated specifically by HDAC3. Acetylation of the 221 lysine residue of p65 was shown to enhance the DNA binding properties of p65. Additionally, they demonstrated that HDAC3 mediated deacetylation of p65 not only decreased the affinity of p65 for the DNA, but also potentiated the interaction of p65 with IB-␣, consequently leading to the export of the p65/IB-␣ complex to the cytoplasm. Based on this evidence, the authors suggested that reversible acetylation of intra-nuclear p65 regulated not only the duration of the NF-B mediated transcriptional response but also contributed to the replenishment of the depleted cytoplasmic pool of latent NF-B/IB-␣ complexes, thereby preparing the cell for any further NF-B inducing signal. In a series of interesting follow-on experiments the authors not only reported that acetylation of another residuelysine 310 -was important for NF-B activation, but they also explored the contribution of a combination of phosphorylation and acetylation on NF-B and observed that prior phosphorylation of p65 at Ser 276 or Ser 536 facilitated the acetylation of p65 at lysine 310
Sumoylation
Sumolytion, another form of post-translational modification, is mediated by the small ubiquitin like modifier (SUMO) family of
proteins [81, 82] [83, 84] . Within the nucleus, sumoylated proteins have been shown to accumulate as nuclear speckles. Indeed, the machinery required for sumoylation is generally found in the nucleus as are the majority of proteins known to be sumoylated [85] . Different families of proteins can undergo sumoylation, including transcription factors and co-factors such as CBP/p300 [82] . So far three proteins involved in the NF-B signalling have been demonstrated to be sumoylated. Sumoylation prevents the stimulus induced ubiquitination and degradation of IB-␣ [86] . However unlike ubiquitintion, this process has been shown to occur within the nucleus [85] . Interestingly sumoylation and ubiquitination target the same lysine residue indicating that stimulation specific post-translational modification of the critical lysine residue of IB-␣ determines the fate of the protein [86] . [88] . Finally IKK␥/NEMO, normally the non-catalytic member of the IKK complex, has also been reported to undergo sumoylation. However, in this case NEMO is unbound to the IKK complex and sumoylation occurs in response to genotoxic stimuli such as heat shock and oxidative stress. The modified NEMO protein subsequently translocates to the nucleus where it is thought to repress NF-B activity [33, 81] . It should be noted that the process of sumoylation is not only dynamic and reversible but also very subtle making it difficult to identify the effects of this post-translational modification. [89, 90] .
PIAS1, an E3 ligase, has been shown to directly interact with the transactivation domain of the p65 subunit of NF-B. This prevents the NF-B -DNA binding reducing the expression of target genes including IB-␣ [87]. Another SUMO E3 ligase, PIAS3, was shown to compete with CBP for binding with the Rel homology domain domain of p65 consequently suppressing NF-B activity
Nuclear regulators of NF-B: potential molecular chaperones
The importance of molecular chaperones has been clearly outlined in circumstances of cellular stress where they are required for the trafficking of misfolded proteins [91] [59, [96] [97] [98] . RXR belongs to a family of ligand-dependent transcriptional regulatory proteins and is an obligatory binding partner of several nuclear receptors including PXR/SXR [99] . In addition, Bcl-3 interacts with the basal transcription machinery including such members as TFIIA, TFIIB and TBP [96] . Bcl-3 has also been associated with other co-activators such as CBP/p300, TORC3 and SRC-1 and it is known to recruit HDACs to transcriptional complexes [100] (Fig. 3) 
